Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting

NCT03808688 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

261

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma, Open-Angle
Ocular Hypertension

Interventions

DRUG: Netarsudil Ophthalmic Solution 0.02%

Sponsor

Aerie Pharmaceuticals